Adjuvant AI Combined With Zoladex
NCT01352091
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
670
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Zoladex+AI
DRUG:
TAM
Sponsor
Fudan University